fusidic acid has been researched along with clavulanic acid in 6 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (clavulanic acid) | Trials (clavulanic acid) | Recent Studies (post-2010) (clavulanic acid) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 1,801 | 212 | 424 |
Protein | Taxonomy | fusidic acid (IC50) | clavulanic acid (IC50) |
---|---|---|---|
Beta-lactamase | Klebsiella pneumoniae | 1.72 | |
Beta-lactamase | Escherichia coli | 0.07 | |
Beta-lactamase | Citrobacter gillenii | 0.009 | |
Beta-lactamase | Shouchella clausii | 0.085 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.1 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.1 | |
Beta-lactamase | Staphylococcus aureus | 0.08 | |
Beta-lactamase | Escherichia coli K-12 | 0.015 | |
Beta-lactamase SHV-1 | Escherichia coli | 0.028 | |
Beta-lactamase SHV-1 | Klebsiella pneumoniae | 0.17 | |
Beta-lactamase OXA-1 | Escherichia coli | 3.2 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 0.17 | |
Beta-lactamase | Pseudomonas aeruginosa PAO1 | 0.8 | |
Beta-lactamase TEM | Escherichia coli | 0.0933 | |
Beta-lactamase | Salmonella enterica subsp. enterica serovar Westhampton | 0.01 | |
Beta-lactamase | Pseudomonas aeruginosa | 0.1 | |
Beta-lactamase | Klebsiella pneumoniae | 0.02 | |
Class D beta-lactamase | Brachyspira pilosicoli | 2 | |
Beta-lactamase | Pseudomonas luteola | 0.036 | |
Beta-lactamase | Escherichia coli | 8.6 | |
Beta-lactamase | Escherichia coli | 0.009 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Mazereeuw-Hautier, J | 1 |
Guan, J; Li, B; Qin, L; Zhang, G | 1 |
Bassi, A; Neri, I; Patrizi, A | 1 |
Neugebauer, D; Niesyto, K | 1 |
1 review(s) available for fusidic acid and clavulanic acid
Article | Year |
---|---|
[Impetigo].
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Azithromycin; Cephalosporins; Child; Clavulanic Acid; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Impetigo; Infant; Male; Methicillin; Mupirocin; Ointments; Penicillins; Pregnancy; Pristinamycin; Sulfadiazine; Time Factors | 2006 |
5 other study(ies) available for fusidic acid and clavulanic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
In vitro synergistic antibacterial activities of helvolic acid on multi-drug resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacillus cereus; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fusidic Acid; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 2009 |
Streptococcal intertrigo.
Topics: Amoxicillin; Clavulanic Acid; Female; Fusidic Acid; Humans; Infant; Intertrigo; Skin Diseases, Bacterial; Streptococcal Infections | 2015 |
Linear Copolymers Based on Choline Ionic Liquid Carrying Anti-Tuberculosis Drugs: Influence of Anion Type on Physicochemical Properties and Drug Release.
Topics: Aminosalicylic Acid; Anions; Antitubercular Agents; Choline; Clavulanic Acid; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fusidic Acid; Hydrophobic and Hydrophilic Interactions; Ionic Liquids; Micelles; Piperacillin; Polymers; Proton Magnetic Resonance Spectroscopy; Spectrophotometry | 2020 |